Dyne Therapeutics Inc. – Filings and Transcripts

NASDAQ: DYN
Share price (6/3/26): $17.99
Market cap (6/3/26): $2.974 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

T. Rowe Price Investment Management, Inc.

Janus Henderson Group plc

Friedl-Naderer Johanna

News Filter

Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1

Reports First Quarter 2026 Financial Results and Recent Business Highlights

Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Investor Presentation

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness